The Embassy of the Republic of Korea to the UAE, the Department of Health Abu Dhabi, and the Abu Dhabi Stem Cell Center (ADSCC) are set to co-host the conference Medical Korea 2024 in the UAE: Innovation and Collaboration: New Horizons in Biohealth on September 25, 2024, at the Dusit Thani Hotel in Abu Dhabi.
Organized by the Korea Health Industry Development Institute (KHIDI), the event aims to showcase South Korea's advancements in biopharmaceuticals and regenerative medicine, fostering collaboration between Korean and UAE partners in these cutting-edge fields. The conference is supported by cooperative partners, including the Korea Biomedicine Industry Association (KoBIA), the Korea Fund for Regenerative Medicine (KFRM), the Korea Institute of Toxicology (KIT), and the Korea Development Bank's Abu Dhabi branch.
The conference promises to be a hub of innovation and networking, featuring presentations from 14 representatives of Korean biopharmaceutical companies, along with notable speakers from the public and private sectors in the UAE, such as DOH, ADSCC, and ADCAN Pharma. In addition, exhibition booths hosted by KoBIA, KFRM, and participating Korean companies will provide attendees with direct access to industry leaders and their cutting-edge technologies.
Medical Korea 2023, organized by KHIDI last year, was similarly designed to foster collaboration between Korea and the UAE in the healthcare industry.
The event will be structured into three main sessions, each providing comprehensive insights into various aspects of biohealth innovation:
Session 1: Collaboration between Korea and the UAE in advanced regenerative medicines
Session 2: Exploring cell and gene therapy
Session 3: Innovative therapeutics and technologies
These carefully curated sessions will offer attendees an in-depth understanding of the latest trends and breakthroughs in the field, covering topics such as cell and gene therapies, tissue-engineered products, and novel therapeutics. By encompassing the entire spectrum of biohealth innovations, the conference aims to provide a clearer perspective on the industry's current landscape and future potential.
The event is expected to serve as a catalyst for new partnerships and collaborative research initiatives in the rapidly evolving field of biohealth. It is anticipated to generate significant interest and foster new partnerships between Korean and UAE entities, potentially leading to groundbreaking developments in patient care and medical technology.
Furthermore, the conference will emphasize the strategic importance of biohealth cooperation between Korea and the UAE. Discussions will explore how this collaboration can significantly advance healthcare innovation and improve patient outcomes in both countries.
By showcasing South Korea's prowess in advanced biopharmaceuticals and regenerative medicine and reinforcing the UAE's commitment to embracing innovative healthcare solutions, the event is expected to highlight the synergy between the two nations. This collaboration in biohealth is poised to yield substantial benefits for the healthcare sectors of both countries.
As Abu Dhabi continues to position itself as a global leader in healthcare innovation, this conference aligns perfectly with the Emirate's vision. It will provide a platform for exploring cutting-edge biohealth technologies that can significantly enhance patient care and healthcare delivery in the UAE and beyond.
For more information about the conference and registration details, including B2B meetings, please visit: https://mco.eventsair.com/medical-korea-2024-in-uae/registration/Site/Register
